Summary
This narrative review by Kullo (2025) examines the present state of polygenic risk score deployment in clinical medicine, as published in Nature Reviews Genetics. The paper identifies substantive barriers to widespread adoption—likely encompassing technical, infrastructural, and interpretive challenges—and outlines prospective directions for integrating PRS into routine clinical practice. Whilst not directly concerned with farming or soil health, the work is relevant to Pulse Brain insofar as polygenic risk stratification may increasingly inform personalised dietary and lifestyle recommendations grounded in genetic predisposition to metabolic or cardiovascular disease.
Regional applicability
The UK, through the NHS Genomics Medicine Service and initiatives such as the 100,000 Genomes Project, is actively developing infrastructure for genomic medicine; findings on PRS implementation barriers and solutions may directly inform UK policy and practice in precision medicine. However, equity and access challenges noted in the review may be particularly acute in the NHS given resource constraints.
Key measures
Current clinical adoption rates of polygenic risk scores; identified barriers to implementation; proposed frameworks for clinical integration
Outcomes reported
The paper examines the current clinical implementation of polygenic risk scores (PRS), identifying barriers to their adoption and proposing pathways for future clinical utility. It appears to assess readiness for PRS use in personalised medicine and disease risk stratification.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.